DCGI emergency use nod for Covaxin, Corbevax and ZyCoV-D across age groups

Covaxin bags approval for 6-12-year age group, Corbevax for 5-12 group, and ZyCoV-D for 12 years and above

The Drug Controller General of India (DCGI) on Tuesday granted emergency use approvals to COVID-19 vaccines Covaxin, Corbevax and ZyCoV-D.

While the emergency use authorisation (EUA) was granted to Bharat Biotech's Covaxin for the age group of 6-12 years, Biological E's Corbevax bagged the nod for 5-12 years age group and Zydus Lifesciences Ltd.'s ZyCoV-D for 12 years and above.

Despite the EUA, a final decision on rolling out the vaccines will be taken by the government's expert body. Currently, Corbevax for 12-14 years and Covaxin for adolesecents are being administered in the country.

With this approval, Zydus's ZyCoV-D vaccine